Profile change history

What changed for Vasopressin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Vasopressin identity.

83Total events
83Record additions
0Version changes
17Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 83 connected records →

Showing the latest 83 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00269685

PeptideScanner retained ClinicalTrials.gov record NCT00269685 at 2026-11-15T22:08:31.832Z. Its registry update date was 2006-05-29, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 29, 2006
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00358579

PeptideScanner retained ClinicalTrials.gov record NCT00358579 at 2026-11-15T22:08:31.832Z. Its registry update date was 2017-03-17, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
March 17, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00379522

PeptideScanner retained ClinicalTrials.gov record NCT00379522 at 2026-11-15T22:08:31.832Z. Its registry update date was 2014-11-05, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
November 5, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00628550

PeptideScanner retained ClinicalTrials.gov record NCT00628550 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-09-17, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
September 17, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00748072

PeptideScanner retained ClinicalTrials.gov record NCT00748072 at 2026-11-15T22:08:31.832Z. Its registry update date was 2015-01-13, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
January 13, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00886262

PeptideScanner retained ClinicalTrials.gov record NCT00886262 at 2026-11-15T22:08:31.832Z. Its registry update date was 2018-10-17, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 17, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01093768

PeptideScanner retained ClinicalTrials.gov record NCT01093768 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-12-17, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
December 17, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01318278

PeptideScanner retained ClinicalTrials.gov record NCT01318278 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-02-20, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 20, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01393704

PeptideScanner retained ClinicalTrials.gov record NCT01393704 at 2026-11-15T22:08:31.832Z. Its registry update date was 2018-02-15, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 15, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01611935

PeptideScanner retained ClinicalTrials.gov record NCT01611935 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-05-21, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 21, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01700478

PeptideScanner retained ClinicalTrials.gov record NCT01700478 at 2026-11-15T22:08:31.832Z. Its registry update date was 2013-02-11, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 11, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01718613

PeptideScanner retained ClinicalTrials.gov record NCT01718613 at 2026-11-15T22:08:31.832Z. Its registry update date was 2018-05-18, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 18, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01800877

PeptideScanner retained ClinicalTrials.gov record NCT01800877 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-03-12, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
March 12, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01861015

PeptideScanner retained ClinicalTrials.gov record NCT01861015 at 2026-11-15T22:08:31.832Z. Its registry update date was 2016-01-22, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
January 22, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01962870

PeptideScanner retained ClinicalTrials.gov record NCT01962870 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-05-24, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 24, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02118467

PeptideScanner retained ClinicalTrials.gov record NCT02118467 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-01-13, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
January 13, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02223429

PeptideScanner retained ClinicalTrials.gov record NCT02223429 at 2026-11-15T22:08:31.832Z. Its registry update date was 2017-06-05, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
June 5, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02975999

PeptideScanner retained ClinicalTrials.gov record NCT02975999 at 2026-11-15T22:08:31.832Z. Its registry update date was 2024-10-24, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 24, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03930069

PeptideScanner retained ClinicalTrials.gov record NCT03930069 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-04-29, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 29, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04501861

PeptideScanner retained ClinicalTrials.gov record NCT04501861 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 27, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04592744

PeptideScanner retained ClinicalTrials.gov record NCT04592744 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
June 12, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05506319

PeptideScanner retained ClinicalTrials.gov record NCT05506319 at 2026-11-15T22:08:31.832Z. Its registry update date was 2025-03-14, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
March 14, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05568160

PeptideScanner retained ClinicalTrials.gov record NCT05568160 at 2026-11-15T22:08:31.832Z. Its registry update date was 2025-12-22, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
December 22, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05738148

PeptideScanner retained ClinicalTrials.gov record NCT05738148 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-04-09, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 9, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05958342

PeptideScanner retained ClinicalTrials.gov record NCT05958342 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 30, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06217562

PeptideScanner retained ClinicalTrials.gov record NCT06217562 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
August 3, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06547892

PeptideScanner retained ClinicalTrials.gov record NCT06547892 at 2026-11-15T22:08:31.832Z. Its registry update date was 2025-04-13, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 13, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06709573

PeptideScanner retained ClinicalTrials.gov record NCT06709573 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
August 31, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07614438

PeptideScanner retained ClinicalTrials.gov record NCT07614438 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-06-02, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
June 2, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07633600

PeptideScanner retained ClinicalTrials.gov record NCT07633600 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-10-22, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 22, 2026
Evidence lane
Clinical trials
Record added

Federal Register notice 2012-12040

The Federal Register published notice 2012-12040, attributed to FDA and its parent HHS department, on 2012-05-18. Its official title is “Determination That PITRESSIN TANNATE IN OIL (Vasopressin Tannate) Injection, 5 Pressor Units/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 18, 2012
Evidence lane
Regulatory
Record added

Federal Register notice 2018-18614

The Federal Register published notice 2018-18614, attributed to FDA and its parent HHS department, on 2018-08-28. Its official title is “List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
August 28, 2018
Evidence lane
Regulatory
Record added

Federal Register notice 2019-03810

The Federal Register published notice 2019-03810, attributed to FDA and its parent HHS department, on 2019-03-04. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
March 4, 2019
Evidence lane
Regulatory
Record added

Federal Register notice 2019-18932

The Federal Register published notice 2019-18932, attributed to FDA and its parent HHS department, on 2019-09-03. Its official title is “List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
September 3, 2019
Evidence lane
Regulatory
Record added

Federal Register notice 2020-16649

The Federal Register published notice 2020-16649, attributed to FDA and its parent HHS department, on 2020-07-31. Its official title is “List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
July 31, 2020
Evidence lane
Regulatory
Record added

Federal Register notice 2020-26133

The Federal Register published notice 2020-26133, attributed to FDA and its parent HHS department, on 2020-11-25. Its official title is “Termination of the Food and Drug Administration's Unapproved Drugs Initiative; Request for Information Regarding Drugs Potentially Generally Recognized as Safe and Effective,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
November 25, 2020
Evidence lane
Regulatory
Record added

Federal Register notice 2026-11062

The Federal Register published notice 2026-11062, attributed to FDA and its parent HHS department, on 2026-06-03. Its official title is “Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
June 3, 2026
Evidence lane
Regulatory
Record added

Federal Register notice 2026-13492

The Federal Register published notice 2026-13492, attributed to FDA and its parent HHS department, on 2026-07-06. Its official title is “Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
July 6, 2026
Evidence lane
Regulatory
Record added

Federal Register notice 98-25713

The Federal Register published notice 98-25713, attributed to FDA and its parent HHS department, on 1998-09-25. Its official title is “Parke-Davis Pharmaceutical Research et al.; Withdrawal of Approval of 14 New Drug Applications and 13 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
September 25, 1998
Evidence lane
Regulatory
Record added

Plasma concentrations of peptide hormones: Unrealistic levels of vasopressin (AVP), oxytocin (OXT), and brain natriuretic peptide (BNP).

PubMed lists PMID 39034759 in Acta physiologica (Oxford, England) as Journal Article, Review, with publication-date metadata of 2024-07-22 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 30, 2026
Evidence lane
Literature metadata
Record added

Arginine vasopressin deficiency onset after COVID-19 vaccination with positive anti-rabphilin-3A antibodies: a case report and literature review.

PubMed lists PMID 39107738 in BMC endocrine disorders as Case Reports, Journal Article, Review, with publication-date metadata of 2024-08-06 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 13, 2024
Evidence lane
Literature metadata
Record added

Hyponatremia due to preserved non-osmotic arginine vasopressin secretion in adipsic diabetes insipidus: a case report with review of literature.

PubMed lists PMID 39111874 in Endocrine journal as Case Reports, Journal Article, Review, with publication-date metadata of 2024-08-07 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 4, 2025
Evidence lane
Literature metadata
Record added

International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).

PubMed lists PMID 39438674 in Nature reviews. Nephrology as Journal Article, Review, Consensus Statement, with publication-date metadata of 2024-10-22 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 1, 2026
Evidence lane
Literature metadata
Record added

Role of oxytocin and vasopressin in alcohol use disorder.

PubMed lists PMID 39523056 in International review of neurobiology as Journal Article, Review, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, with publication-date metadata of 2024-10-08 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 21, 2026
Evidence lane
Literature metadata
Record added

The Role of Oxytocin and Vasopressin in People with Borderline Personality Disorder: A Closer Look at Adolescents.

PubMed lists PMID 39596113 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2024-11-09 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 13, 2024
Evidence lane
Literature metadata
Record added

Evidence for the contribution of vasopressin V1B receptors in the pathophysiology of depression.

PubMed lists PMID 39608503 in Biochemical pharmacology as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-11-26 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 21, 2025
Evidence lane
Literature metadata
Record added

Hemodynamic Management with Vasopressin for Cardiovascular Surgery.

PubMed lists PMID 39768943 in Medicina (Kaunas, Lithuania) as Journal Article, Review, with publication-date metadata of 2024-12-16 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 10, 2025
Evidence lane
Literature metadata
Record added

[Revisiting the vasopressin V2 receptor].

PubMed lists PMID 39780566 in Sheng li xue bao : [Acta physiologica Sinica] as Journal Article, Review, English Abstract, with publication-date metadata of 2024-12-25 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 9, 2025
Evidence lane
Literature metadata
Record added

Vasopressin in traumatic hemorrhagic shock.

PubMed lists PMID 39936940 in Current opinion in anaesthesiology as Journal Article, Systematic Review, with publication-date metadata of 2025-01-20 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 23, 2025
Evidence lane
Literature metadata
Record added

Aptamers and MIPs as alternative molecular recognition elements for vasopressin and oxytocin sensing: A review.

PubMed lists PMID 40023907 in Biosensors & bioelectronics as Journal Article, Review, with publication-date metadata of 2025-02-23 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 10, 2025
Evidence lane
Literature metadata
Record added

Vasopressin and steroids in addition to adrenaline in cardiac arrest (VAST-A) - A randomised pilot study.

PubMed lists PMID 40154876 in Resuscitation as Journal Article, Randomized Controlled Trial, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-03-26 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 30, 2026
Evidence lane
Literature metadata
Record added

Arginine vasopressin and copeptin: comparative review and perspective in veterinary medicine.

PubMed lists PMID 40160705 in Frontiers in veterinary science as Journal Article, Review, with publication-date metadata of 2025-03-14 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 2, 2025
Evidence lane
Literature metadata
Record added

Management of Arginine Vasopressin Deficiency (Central Diabetes Insipidus) in Neonates and Infants.

PubMed lists PMID 40602377 in Hormone research in paediatrics as Journal Article, Review, with publication-date metadata of 2025-07-02 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 16, 2026
Evidence lane
Literature metadata
Record added

Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?

PubMed lists PMID 40731360 in Critical care (London, England) as Journal Article, Review, with publication-date metadata of 2025-07-29 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 2, 2025
Evidence lane
Literature metadata
Record added

A Scoping Review on Salivary Oxytocin and Vasopressin Measurement in the Dog.

PubMed lists PMID 40867749 in Animals : an open access journal from MDPI as Journal Article, Review, with publication-date metadata of 2025-08-18 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 25, 2026
Evidence lane
Literature metadata
Record added

Copeptin as a Marker for Vasopressin Dysregulation and Diagnosis.

PubMed lists PMID 41070791 in The journal of applied laboratory medicine as Journal Article, Review, with publication-date metadata of 2026-01-05 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 6, 2026
Evidence lane
Literature metadata
Record added

Arginine vasopressin deficiency after surgical ligation of an unruptured anterior communicating artery aneurysm - a case report and literature review.

PubMed lists PMID 41341140 in Frontiers in endocrinology as Journal Article, Case Reports, Review, with publication-date metadata of 2025-11-18 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 31, 2025
Evidence lane
Literature metadata
Record added

Arginine Vasopressin Deficiency and Oxytocin Deficiency in the Endocrine Clinic.

PubMed lists PMID 41363127 in The Journal of clinical endocrinology and metabolism as Journal Article, Review, with publication-date metadata of 2026-03-17 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Arginine Vasopressin (AVP) Deficiency: Diagnosis and Treatment - An Update.

PubMed lists PMID 41497289 in Indian journal of endocrinology and metabolism as Journal Article, Review, with publication-date metadata of 2025-12-19 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 9, 2026
Evidence lane
Literature metadata
Record added

Pediatric Central Diabetes Insipidus due to Arginine Vasopressin Deficiency in the Perianesthetic Period.

PubMed lists PMID 41552892 in Paediatric anaesthesia as Journal Article, Review, with publication-date metadata of 2026-01-19 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 26, 2026
Evidence lane
Literature metadata
Record added

From cranial diabetes insipidus to vasopressin deficiency: terminology, tests and treatment.

PubMed lists PMID 41667271 in Archives of disease in childhood as Journal Article, Review, Case Reports, with publication-date metadata of 2026-08-19 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 31, 2026
Evidence lane
Literature metadata
Record added

Acquired transient vasopressin deficiency by cannabinoids and other substances.

PubMed lists PMID 41668460 in Endocrinology as Journal Article, Review, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 7, 2026
Evidence lane
Literature metadata
Record added

Oxytocin, vasopressin, and their crosstalk in sexually-dimorphic psychiatric conditions.

PubMed lists PMID 41862144 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-03-18 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 5, 2026
Evidence lane
Literature metadata
Record added

Vasopressin 1a Receptor Antagonists for Pathological Aggression in Neurodegenerative and Other CNS Diseases.

PubMed lists PMID 42072430 in Biomedicines as Journal Article, Review, with publication-date metadata of 2026-04-14 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Vasopressin Versus Norepinephrine As First-Line Vasopressor Therapy for Vasoplegic Shock Following Cardiac Surgery: A Systematic Review.

PubMed lists PMID 42583609 in Cureus as Journal Article, Review, with publication-date metadata of 2026-07-12 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Pharmacological mechanisms and clinical evidence of vasopressin, steroids, and epinephrine triple therapy in in-hospital cardiac arrest.

PubMed lists PMID 42609684 in Frontiers in cardiovascular medicine as Journal Article, Review, with publication-date metadata of 2026-08-03 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 19, 2026
Evidence lane
Literature metadata
Record added

The vasopressin system as an immunoneuroendocrine therapeutic target in inflammatory conditions.

PubMed lists PMID 42647984 in Current opinion in pharmacology as Journal Article, Review, with publication-date metadata of 2026-08-10 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 8, 2026
Evidence lane
Literature metadata
Record added

Important Role of Renin-Angiotensin System and Vasopressin System in Cardiovascular, Metabolic and Psychogenic Disorders in Pregnancy and Early Postnatal Life: A Narrative Review.

PubMed lists PMID 42653310 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2026-08-16 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 29, 2026
Evidence lane
Literature metadata
Record added

Arginine vasopressin deficiency: towards a better characterization.

PubMed lists PMID 42677919 in Endocrine-related cancer as Journal Article, Review, with publication-date metadata of 2026-09-01 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 18, 2026
Evidence lane
Literature metadata